Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
Deciphering the Mechanisms of Medulloblastoma Treatment Resistance using Integrative Genomics |
Hospital for Sick Children / Vijay Ramaswamy, MD |
Young Investigator Grants |
2014 |
Ontario |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis |
University of Minnesota / Beau Webber, PhD |
Young Investigator Grants |
2017 |
Minnesota |
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Resistance to anti-angiogenic therapy in pediatric solid tumors.
|
Feinstein Institute for Medical Research - North Shore / Samuel Soffer, MD |
Young Investigator Grants |
2007 |
New York |
Novel Genomic Drivers in Pediatric Polyposis Syndromes |
Children’s Hospital of Philadelphia / Suzanne MacFarland, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma |
Boston Children’s Hospital / John Powers |
Young Investigator Grants |
2012 |
Massachusetts |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Investigation of Oncogenic Long Non-coding RNAs in Ewing sarcoma |
Lucile Packard Children’s Hospital at Stanford University School of Medicine / Siu Ping Ngok, PhD |
Young Investigator Grants |
2014 |
California |